Language Selector

    Innovative Medicines Initiative has Launched Call 17 Today

    Published on 22 January 2019
    Author: Sasha Hugentobler, National Contact Point Health

    Call 17 is a standard two-stage call for proposals with some interesting topics - have a closer look!

    The Innovative Medicines Initiative has now launched IMI2 – Call 17.

    These topics address academics, SMEs, mid-sized enterprises, patient groups, regulators, and others working in areas as diverse as medical research, drug development, public health and more.  

    Call 17 is a standard two-stage call for proposals with the following topics: 

    • Optimising future obesity treatment
    • Open access chemogenomics library and chemical probes for the druggable genome
    • Intelligent prediction and identification of environmental risks posed by human medicinal products 

    Deadline for short proposals: 25 April 2019

    You can find the call web page here.

    All topic texts, call documentation and details of how to apply can be found on the IMI website


    +++ information on webinars +++

    IMI is currently running webinars on IMI2 – Call 17, including webinars on all call topics, as well as IMI’s rules and procedures and opportunities for small and medium-sized enterprises (SMEs). Tips on finding partners and preparing your proposal.

    Why apply? - IMI calls for proposals represent an excellent opportunity for researchers to take part in ground-breaking collaborative projects that aim to deliver tangible benefits for patients. Scientists from academia, industry, SMEs, mid-sized companies, hospitals and patients’ organisations are encouraged to get involved in projects.

    Questions? E-mail applicants@imi.europa.eu

    You can find more information on these webinars here.